Opportunities To Accelerate Decentralized And Digital Trials

There are many challenges in bringing new drug therapies to market, but one of the most pressing is how life sciences organizations can rapidly harness, organize and analyze the increasing volume and variety of clinical data that are now available. This is clearly demonstrated in the fact that the amount of clinical data per trial has grown by 183% in the last decade.¹

Clinical research hinges on high quality data, and the rate at which this data is expanding represents a larger trend in drug development. Life sciences companies are now managing studies that are more complex than ever before. Trials now have more than 70% of their data coming from outside of EDC systems including numerous types of labs, eCOA platforms, decentralized trial systems and numerous other clinical data sources.

Learn about the need for investment in modern technology platforms to successfully handle the influx of new data streams available in research today, as well as those coming in the future.